Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects

Significance Mutations of SCN1A, a gene encoding the Nav1.1 Na+ channel, can cause familial hemiplegic migraine (FHM-3) or epilepsy. Epileptogenic mutations induce reduction of its function, leading to decreased excitability of GABAergic neurons, but studies of FHM-3 mutations have generated confusing results. We have reported gain-of-function effects, but complete loss of function has been reported for the mutant L1649Q, a paradoxical result. Here we show that L1649Q function can be rescued in conditions that more closely model real conditions in neurons. When partially rescued, L1649Q shows gain of function and can induce neuronal hyperexcitability, consistently with hyperexcitability of GABAergic neurons as the cause of FHM-3. Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura. Mutations causing FHM type 3 have been identified in SCN1A, the gene encoding the Nav1.1 Na+ channel, which is also a major target of epileptogenic mutations and is particularly important for the excitability of GABAergic neurons. However, functional studies of NaV1.1 FHM mutations have generated controversial results. In particular, it has been shown that the NaV1.1-L1649Q mutant is nonfunctional when expressed in a human cell line because of impaired plasma membrane expression, similarly to NaV1.1 mutants that cause severe epilepsy, but we have observed gain-of-function effects for other NaV1.1 FHM mutants. Here we show that NaV1.1-L1649Q is nonfunctional because of folding defects that are rescuable by incubation at lower temperatures or coexpression of interacting proteins, and that a partial rescue is sufficient for inducing an overall gain of function because of the modifications in gating properties. Strikingly, when expressed in neurons, the mutant was partially rescued and was a constitutive gain of function. A computational model showed that 35% rescue can be sufficient for inducing gain of function. Interestingly, previously described folding-defective epileptogenic NaV1.1 mutants show loss of function also when rescued. Our results are consistent with gain of function as the functional effect of NaV1.1 FHM mutations and hyperexcitability of GABAergic neurons as the pathomechanism of FHM type 3.

[1]  Massimo Mantegazza,et al.  Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine , 2013, Epilepsia.

[2]  C. H. Thompson,et al.  Nontruncating SCN1A Mutations Associated with Severe Myoclonic Epilepsy of Infancy Impair Cell Surface Expression* , 2012, The Journal of Biological Chemistry.

[3]  Dania Vecchia,et al.  Migraine: a disorder of brain excitatory–inhibitory balance? , 2012, Trends in Neurosciences.

[4]  William A Catterall,et al.  Autistic behavior in Scn1a+/− mice and rescue by enhanced GABAergic transmission , 2012, Nature.

[5]  M. Avoli,et al.  Jasper's basic mechanisms of the epilepsies , 2012 .

[6]  K. Yamakawa,et al.  Different degrees of loss of function between GEFS+ and SMEI Nav1.1 missense mutants at the same residue induced by rescuable folding defects , 2012, Epilepsia.

[7]  S. Franceschetti,et al.  Pure haploinsufficiency for Dravet syndrome NaV1.1 (SCN1A) sodium channel truncating mutations , 2012, Epilepsia.

[8]  Lori L. Isom,et al.  Na+ Channel β Subunits: Overachievers of the Ion Channel Family , 2011, Front. Pharmacol..

[9]  M. Mantegazza Dravet syndrome: Insights from in vitro experimental models , 2011, Epilepsia.

[10]  G. Avanzini,et al.  Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again , 2010, Epilepsy Research.

[11]  W. Catterall,et al.  NaV1.1 channels and epilepsy , 2010, The Journal of physiology.

[12]  M. Meisler,et al.  Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects , 2010, The Journal of physiology.

[13]  D. Shao,et al.  Protein-protein interactions involving voltage-gated sodium channels: Post-translational regulation, intracellular trafficking and functional expression. , 2009, The international journal of biochemistry & cell biology.

[14]  S. Franceschetti,et al.  A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: Common mechanism in Nav1.1 related epilepsies? , 2009, Human mutation.

[15]  A. L. Goldin,et al.  A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation , 2009, Neurobiology of Disease.

[16]  M. Ferrari,et al.  Molecular genetics of migraine , 2009, Human Genetics.

[17]  Massimo Mantegazza,et al.  Self-Limited Hyperexcitability: Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+ Channel , 2008, The Journal of Neuroscience.

[18]  M. Ferrari,et al.  Divergent sodium channel defects in familial hemiplegic migraine , 2008, Proceedings of the National Academy of Sciences.

[19]  I. Scheffer,et al.  Navigating the channels and beyond: unravelling the genetics of the epilepsies , 2008, The Lancet Neurology.

[20]  S. Franceschetti,et al.  Modulatory Proteins Can Rescue a Trafficking Defective Epileptogenic Nav1.1 Na+ Channel Mutant , 2007, The Journal of Neuroscience.

[21]  Hiroyuki Miyamoto,et al.  Nav1.1 Localizes to Axons of Parvalbumin-Positive Inhibitory Interneurons: A Circuit Basis for Epileptic Seizures in Mice Carrying an Scn1a Gene Mutation , 2007, The Journal of Neuroscience.

[22]  Martin Dichgans,et al.  The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies , 2007, Human mutation.

[23]  S. Tuft,et al.  Novel SLC4A11 mutations in patients with recessive congenital hereditary endothelial dystrophy (CHED2) , 2007, Human mutation.

[24]  G. Avanzini,et al.  Effects in Neocortical Neurons of Mutations of the Nav1.2 Na+ Channel causing Benign Familial Neonatal-Infantile Seizures , 2006, The Journal of Neuroscience.

[25]  Massimo Mantegazza,et al.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy , 2006, Nature Neuroscience.

[26]  A. L. Goldin,et al.  An Epilepsy Mutation in the Sodium Channel SCN1A That Decreases Channel Excitability , 2006, Journal of Neuroscience.

[27]  R. Lipton,et al.  Chronic disorders with episodic manifestations: focus on epilepsy and migraine , 2006, The Lancet Neurology.

[28]  Aldo Quattrone,et al.  Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Ulbricht,et al.  Sodium channel inactivation: molecular determinants and modulation. , 2005, Physiological reviews.

[30]  Michel Bouvier,et al.  Pharmacological chaperones: potential treatment for conformational diseases , 2004, Trends in Endocrinology & Metabolism.